font size:




ProNAi Therapeutics, Inc. is a privately held biopharmaceutical company. To date, the company has raised $15 million in equity and convertible notes.

ProNAi’s institutional investors include:

  • Apjohn Ventures, Kalamazoo, MI
  • Grand Angels, Grand Rapids, MI
  • Michigan Strategic Fund/MEDC
  • Biosciences Research Commercialization Center, Kalamazoo, MI
  • Sigvion Ventures, Chicago, IL
  • Amherst Fund, Ann Arbor, MI
  • BlueWater Angels, Midland, MI